Course objectives:
After the presentation, attendees will be able to:
- Identify the differences in clinical behavior between early onset inflammatory bowel disease (IBD) and IBD in older patients.
- Discuss the diagnostic role of immunophenotyping and genomic testing in select patients with IBD.
- Discuss how a multidisciplinary team can incorporate immunophenotyping and genomics, with more commonly available clinical tools to develop personalized treatment strategies for select individuals with IBD.
Precision Medicine in Action: Inflammatory Bowel Diseases in Young Children
Michael C. Stephens, MD, FAAP
Assistant Professor of Pediatrics - Mayo Clinic College of Medicine
Consultant - Division of Pediatric Gastroenterology and Hepatology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Mayo Clinic College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.